SmithKline Beckman Corp said opened 8.5 mln dlr pharmaceutical manufacturing plant Tianjin , China .
The plant make pharmaceutical product joint venture company , Tianjin Smith Kline French Laboratories .
SmithKline said joint venture combine Smith Kline French Laboratories , pharmaceutical unit SmithKline Beckman , & lt ; Tianjin Medical Co > , & lt ; Hebel Chemical Plant > Tianjin .
The plant capability produce one billion tablet 200 mln capsule year .
Reuter & # 3 ; 